BAX and acute myeloid leukemia: Moreover, the interaction with VDAC2 is critical for BAX to mediate cell death in response to chemotherapeutic agents both in vitro and in vivo, as well as for BAX to limit tumor development in a cMyc-driven model of acute myeloid leukemia (AML).